BNTC: Benitec Corp Price Chart

Benitec Biopharma Inc. (BNTC) develops gene silencing systems, leveraging long-term patent rights and payments from pharma behemoths. The company has implemented AI-driven automation for drug synthesis, although final control remains with medical professionals. Current silencing capacities are fully utilized, while the production of constructs is delegated to reliable contractors. The asset's market dynamics on GURU.Markets, where the indicator stands at 8.98, confirm these fundamental successes.

Benitec Corp - BNTC Price (period 07/04/2022 - 11/14/2026)

Benitec Biopharma Inc (BNTC) - metric breakdowns and financial figures

- stock quotes and analyst forecast:

Stock Price Benitec Biopharma Inc.|BNTC - Price Target Chart

- market capitalization information:

Market Value Benitec Biopharma Inc|BNTC - Business Value

- balance sheet equity data:

Accounting Value per Share Benitec Biopharma|BNTC - Total Net Assets|Market Capitalization to Book Value Ratio benitec.com|BNTC - Cumulative Company Assets

- business debt structure and liquidity details:

- financial results and valuation multiples details:

BNTC - Company Net Income|Expected Profit Benitec Biopharma Inc.|BNTC - Price to Earnings Multiple|Forward P/E Multiple Benitec Biopharma|BNTC - Growth-Adjusted Market Cap to Net Income|Enterprise Value to EBITDA Ratio Benitec Biopharma Inc|BNTC - Company profit before taxes, interest and amortization|Net earnings per share (EPS TTM) Benitec Biopharma|BNTC - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth benitec.com|BNTC - Net earnings per share growth this year|Expected earnings per share growth for next year Benitec Biopharma Inc.

- company sales and revenue statistics:

BNTC - Company Sales Revenue|Projected Sales Volume Benitec Biopharma Inc.|BNTC - Price-to-Revenue Ratio|Forward P/S Multiple Benitec Biopharma Inc

Summary company analytics:Benitec Biopharma Inc.

The price represents the market equivalent of a single share, reflecting the current capitalization of Benitec Biopharma Inc. (BNTC) through a mechanism of continuous fair value discovery. By analyzing the price chart, an investor assesses market expectations, which in this biotechnology sector depend not on macroeconomics, but on clinical trial outcomes and the availability of capital for R&D.

Analysis of competing companies